Kent Imaging
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Early VC | |
N/A | N/A | Early VC | |
N/A | $1.1m | Grant | |
* | $15.0m | Early VC | |
* | CAD1.8m | Grant | |
Total Funding | €15.8m |
Related Content
Recent News about Kent Imaging
EditKent Imaging specializes in advanced diagnostic imaging solutions that evaluate tissue health and optimize treatment outcomes using near-infrared (NIR) technology. The company's flagship product, SnapshotNIR, is designed to assess tissue oxygenation, which is crucial for healing and survival, particularly in reconstructive surgery and wound care. Kent Imaging serves healthcare providers, including hospitals and clinics, by offering tools that inspire patient confidence, enhance compliance, and improve treatment outcomes. Operating in the medical imaging market, Kent Imaging generates revenue through the sale and maintenance of its imaging devices, as well as through associated services and support. The business model focuses on providing innovative, patented technology that aids healthcare systems both nationally and internationally.
Keywords: tissue health, near-infrared imaging, oxygenation, wound care, reconstructive surgery, patient confidence, compliance, treatment outcomes, healthcare providers, patented technology.